Posts

Showing posts with the label Inflammatory Myositis (IM) competitive landscape

Inflammatory Myositis (IM) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Inflammatory myopathies represent a spectrum of muscular disorders characterized by inflammation, stemming from autoimmune dysregulation wherein the body's immune system erroneously targets its own muscle tissues. Predominant among these conditions are dermatomyositis and polymyositis, though the taxonomy of inflammatory myopathies remains dynamic, with ongoing identification of novel subtypes. Dermatomyositis primarily manifests as muscle weakness, notably affecting the musculature of the cervical, scapular, and pelvic regions, and also presents with cutaneous manifestations. Respiratory compromise may also ensue in some instances. While inflammatory myopathies can affect individuals across age groups and ethnicities, their incidence is relatively infrequent, with a predilection for onset in childhood (typically between ages 5 and 10) and adulthood (typically between ages 40 and 50) and a higher occurrence in females compared to males. The clinical evaluation of susp...